Hutch News

Hutch News

Stories tagged 'Matthew Trunnell'

Will the flu vaccine work for you? Answer may be in your genes

Set of 9 genes that predicts flu response in adults under 35 could be first step to personalized vaccine

Aug. 31, 2017 | By Rachel Tompa / Fred Hutch News Service

A newly uncovered set of genes that predicts whether the flu shot will work or not could be the first step toward a personalized flu vaccine.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 19, 2017

Dr. Larry Corey wins $2.6 million grant to explore using CAR T cells for HIV cure; Immune responses against virus-related cancer may provide clues for improved immunotherapy; Hutch/UW symposium underscores Seattle's reputation as "infectious disease central"; Fred Hutch CIO Matthew Trunnell among speakers at SLU Collaborative seminar.

View story >


Microsoft CEO Satya Nadella and other tech, business leaders join Hutch board of trustees

Board will help guide center in ‘achieving the most ambitious goals in cancer research’

July 11, 2016 | By Bill Briggs / Fred Hutch News Service

The new board members will help guide Fred Hutch in ‘achieving the most ambitious goals in cancer research.’

View story >


‘We can get this done’: National Cancer Moonshot takes flight

Moonshot Summit at Fred Hutch part of coast-to-coast conversation to stop cancer

June 29, 2016 | By Bill Briggs / Fred Hutch News Service

For the first time, America talks together Wednesday about ending cancer – from a Cancer Moonshot Summit at Fred Hutchinson Cancer Research Center to hundreds of simultaneous gatherings in all 50 states on the “national day of action” to speed cures.

View story >


The cancer killers

Across research centers, scientists and innovators shelve competition to target a common enemy

June 15, 2016 | By Bill Briggs / Fred Hutch News Service

View story >


Seattle's life sciences scene in the spotlight

Xconomy forum highlights research in vaccines, organ transplants, big data, more

May 3, 2016 | By Rachel Tompa / Fred Hutch News Service

It was a dizzying round-up of Seattle’s life sciences research and biotech scene, from designer proteins to the looming threat of the Zika virus. This year’s forum was titled “Life Sciences Disruptors,” though Lash and the other speakers didn’t focus on the technology buzzword theme, but if there was one common thread to the afternoon’s whirlwind tour of Seattle’s public and private life sciences work it was that which is new and unexpected — and a look to the future of healthcare.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.